EcoDrugPlus

Proteasome 26s Subunit, Non-Atpase 11

Ensembl ID : ENSPVAG00000009767
Gene Symbol: PSMD11
1 Cross references
285 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 12

Ensembl ID : ENSPVAG00000016034
Gene Symbol: PSMD12
1 Cross references
220 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 13

Ensembl ID : ENSPVAG00000017707
Gene Symbol: PSMD13
1 Cross references
221 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 14

Ensembl ID : ENSPVAG00000005415
Gene Symbol: PSMD14
1 Cross references
213 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 3

Ensembl ID : ENSPVAG00000008544
Gene Symbol: PSMD3
1 Cross references
212 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 6

Ensembl ID : ENSPVAG00000014856
Gene Symbol: PSMD6
1 Cross references
212 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 8

Ensembl ID : ENSPVAG00000006551
Gene Symbol: PSMD8
1 Cross references
202 Possible Orthologues:

Proteasome Subunit Beta 11

Ensembl ID : ENSPVAG00000013801
Gene Symbol: PSMB11
1 Cross references
227 Possible Orthologues:

Protein Arginine Methyltransferase 5

Ensembl ID : ENSPVAG00000013786
Gene Symbol: PRMT5
1 Cross references
198 Possible Orthologues:

Protein Kinase C Alpha

Ensembl ID : ENSPVAG00000011066
Gene Symbol: PRKCA
1 Cross references
289 Possible Orthologues:

Protein Kinase C Beta

Ensembl ID : ENSPVAG00000000048
Gene Symbol: PRKCB
1 Cross references
286 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSPVAG00000016280
Gene Symbol: PRKCD
1 Cross references
280 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).